BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 18, 2026
Home » Authors » Khawar Khan

Khawar Khan

Articles

ARTICLES

Conundrum: Pakistan relies on smuggled drugs from India

June 26, 2017
By Khawar Khan
KARACHI, Pakistan – Despite strict laws by the Drug Regulatory Authority of Pakistan that make smuggling medicines into the country a crime punishable by a maximum sentence of 10 years' imprisonment, the problem remains rife.
Read More

Lack of free market policies pushes biopharmas away from Pakistan

May 24, 2017
By Khawar Khan
KARACHI, Pakistan – Facing a chronic lack of regulation, the pharmaceutical industry in Pakistan is struggling to put in place a free market policy to boost the sector and provide quality drugs to a population of more than 200 million.
Read More

Lack of free market policies pushes biopharmas away from Pakistan

May 18, 2017
By Khawar Khan
KARACHI, Pakistan – Facing a chronic lack of regulation, the pharmaceutical industry in Pakistan is struggling to put in place a free market policy to boost the sector and provide quality drugs to a population of over 200 million.
Read More

Pakistan introduces first mobile diagnosis technology that provides rapid test results

April 18, 2017
By Khawar Khan

Pakistan's lack of med tech a cost burden

March 17, 2017
By Khawar Khan

Pakistan's biopharma sector struggles to establish regulations

Feb. 14, 2017
By Khawar Khan
KARACHI, Pakistan – Facing a chronic shortage of regulations, the biopharmaceutical industry in Pakistan is struggling to get traction despite widespread need and huge market potential. With a population that is rapidly approaching 200 million, Pakistan's pharmaceutical sector sees high growth potential, but it's held back by a lack of regulations that often translates into chronic shortages of essential medicines.
Read More

In Pakistan, 'informal' clinical trials raise ethics concerns

Jan. 26, 2017
By Khawar Khan
KARACHI, Pakistan – The death of 57-year-old Javed Iqbal in a private hospital in Karachi, Pakistan's economic hub, has shined a light on growing concerns surrounding clinical trials involving this country of 200 million people. Informal and often unethical clinical trials carried out by doctors are a common problem, according to numerous anecdotal reports.
Read More
View All Articles by Khawar Khan

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing